Hepatocellular adenoma is a rare benign tumor of the liver. However, some complications, such as hemorrhage, rupture, and malignant transformation, have been reported previously. Surgical resection is considered to be the best choice of treatment, when adenomas are increasing in size, while resection is difficult to perform when multiple adenomas develop throughout the liver. Here, we report two cases of multiple hepatocellular adenomatosis. One patient had a history of aplastic anemia and the other had glycogen storage disease. We treated them with transcatheter arterial embolization (TAE) to prevent hemorrhage and rupture. After TAE, most parts of the adenomas showed necrotic change. These cases suggest that TAE is an effective treatment of hepatocellular adenomatosis.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716763 | PMC |
| http://dx.doi.org/10.1007/s12072-009-9126-1 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Genomic and Transcriptomic Profile of HNF1A-Mutated Liver Adenomas Highlights Molecular Signature and Potential Therapeutic Implications.
Int J Mol Sci
September 2024
Immunogenetics and Transplant Biology Service, Azienda Ospedaliera-Universitaria Città della Salute e della Scienza, 10126 Turin, Italy.
Article Synopsis
- - Hepatocellular adenomas (HAs) are liver tumors linked to genetic mutations, with this study focusing on a 17-year-old with multiple HAs and a specific pathogenic mutation known to have a dominant negative effect.
- - The study identified additional somatic variants in some HAs and revealed significant transcriptomic changes, including alterations in various metabolic pathways, angiogenesis, and immune response.
- - Findings provide a detailed molecular profile of HAs associated with the identified mutation, paving the way for possible non-surgical treatment strategies by pinpointing new therapeutic targets.
Androgen-Induced, β-Catenin-Activated Hepatocellular Adenomatosis with Spontaneous External Rupture.
Diagnostics (Basel)
July 2024
Department of Pathology, NYU Langone Medical Center, New York University Grossman School of Medicine, 550 1st Avenue, New York, NY 10016, USA.
Article Synopsis
- Androgens are linked to causing liver tumors, both benign and malignant, such as hepatocellular adenoma and carcinoma, but the exact mechanisms are still unknown.
- A case study of a 24-year-old male who developed an androgen-induced hepatocellular adenoma revealed symptoms like severe abdominal pain and a history of testosterone use, leading to significant complications.
- The diagnosis involved imaging and biopsy, which confirmed atypical liver cells and highlighted the importance of considering androgen-induced liver tumors when diagnosing acute abdominal issues.
Paediatric hepatocellular adenomas: Lessons from a systematic review of relevant literature.
JHEP Rep
June 2024
Centre de recherche des Cordeliers, Sorbonne Université, Inserm, Université Paris Cité, team « Functional Genomics of Solid Tumors », Equipe labellisée Ligue Nationale Contre le Cancer, Labex OncoImmunology, F-75006 Paris, France.
Article Synopsis
- Hepatocellular adenomas (HCAs) are uncommon, benign liver tumors that affect both children and adults differently, necessitating a specific analysis of pediatric cases.
- A comprehensive study involving 316 children revealed that HCAs predominantly occur in girls around the age of 11.5, with a high prevalence linked to predisposing conditions such as glycogen storage disease, portosystemic shunts, and MODY3.
- Notably, complications like bleeding and tumor transformation were common, with management strategies varying based on the underlying diseases and tumor characteristics, including potential surgical interventions like resections or liver transplants.
Hepatocellular Adenoma: Report of 2 Cases That Highlight the Relevance of Phenotype-Genotype Correlation in the Pediatric Population.
Pediatr Dev Pathol
November 2023
Department of Pathology, Yale School of Medicine, New Haven, CT, USA.
Background: Hepatocellular adenoma (HCA) in the pediatric population is very rare and there are only limited studies, especially with molecular characterization of the tumors. Main HCA subtypes recognized in the current WHO classification include -inactivated HCA (H-HCA), inflammatory HCA (IHCA), β-catenin-activated HCA (b-HCA), and β-catenin-activated IHCA (b-IHCA) and sonic hedgehog HCA (shHCA) is reported as an emerging subtype.
Methods: Clinical history, pathological information, and molecular studies for a series of 2 cases of pediatric HCA were reviewed.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!